David P. Roe bought Chemours Co (NYSE: CC)
David P. Roe (R-TN), a U.S. Representative, has disclosed 1 trade in Chemours Co (CC) since 2012, a single purchase, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: David P. Roe bought $15,001 - $50,000 of Chemours Co (NYSE: CC) on August 14, 2012. Since that trade, CC is up +39.32% against the S&P 500 up +569.92%, an outperformance of -530.60%.
Data updated
David P. Roe's CC trades vs the price
CC is up +39.32% since David P. Roe bought on August 14, 2012, versus +569.92% for the S&P 500.
Performance since this trade
All David P. Roe CC trades
David P. Roe & CC trading FAQ
Is it legal for David P. Roe to trade Chemours Co (CC) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Chemours Co (CC), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did David P. Roe buy CC?
David P. Roe disclosed a purchase of $15,001 - $50,000 of Chemours Co (CC) on August 14, 2012, according to public STOCK Act filings.
How has CC performed since David P. Roe's trade?
Since David P. Roe bought CC on August 14, 2012, the stock is up +39.32%, versus +569.92% for the S&P 500 over the same period, an outperformance of -530.60%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CC trades?
Quantellect tracks every disclosed congressional trade in Chemours Co (CC) on the Chemours Co congressional trading page, which aggregates filings across all members of Congress.
David P. Roe's CC tradesAll congressional filings for Chemours CoDavid P. Roe's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.